openPR Logo
Press release

Malaria Diagnostics Market Will Generate New Growth Opportunities in the next upcoming year | Access Bio. Inc., Atlas Medical, Biomérieux SA, Bio-Rad Laboratories, Inc., Meridian Bioscience Inc, Novartis AG

06-18-2021 06:14 AM CET | Health & Medicine

Press release from: Allied Market Research

/ PR Agency: Allied Market Research
Malaria Treatment Market

Malaria Treatment Market

According to a new report published by Allied Market Research, titled, “Malaria Diagnostics Market by Product Type, and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2019–2026,” the global malaria diagnostics market size was valued at $728,870 thousand in 2018, and is expected to reach $1,085,106 thousand by 2026, registering a CAGR of 5.1% from 2019 to 2026.

Request FREE Sample Report at: https://www.alliedmarketresearch.com/request-sample/285

Malaria Treatment Market by Product Type (Rapid Diagnostic Tests, Microscopy, and Molecular Diagnostic Tests) and End User (Hospital, Clinics, Diagnostic Centers) Global Opportunity Analysis and Industry Forecast, 2019–2026

Drivers, restraints, and opportunities-

Rise in incidence of malaria, increase in healthcare expenditure among people, and surge in adoption of malaria diagnostics tools across the world fuel the growth of the global malaria diagnostics market. On the other hand, poor demand in underdeveloped countries restrains the growth to some extent. Nevertheless, development in emerging economies is expected to create a plethora of opportunities in the near future.

COVID-19 Scenario:

• Due to the global pandemic all over the world, the medical devices manufacturers are majorly focusing on essential medical devices production including ventilators and diagnostics.

• However, due to the precautionary measures taken by governments in various regions, the supply chain has been hampered. Which may result in shortage of devices in certain locations.

• Food and Drugs Administration (FDA), on the other hand, shared a COVID-19 guidance with medical device manufacturers to notify the agency about changes that could affect availability of their products.

The major factor that contributes to the growth of malaria diagnostics market include rise in prevalence of malaria in developing countries. Furthermore, rise in awareness initiatives by governments and surge in research for new malaria diagnostics are the factors that boost the growth of the market. However, lack of awareness about healthcare in developing countries is the major factor that restricts growth of the malaria diagnostics market. Conversely, growth opportunities exhibited by emerging economies is expected to offer lucrative opportunities during the forecast period.

LAMEA to maintain the top status till 2026, North America to grow at the third highest CAGR-

Based on geography, LAMEA contributed to 94% of the global malaria diagnostics market revenue in 2018, and is anticipated to maintain the lion’s share till 2026. At the same time, the Asia-Pacific region would showcase the fastest CAGR of 6.1% during the study period. Surge in awareness regarding the use of antimalarial drugs in this region has propelled the growth. However, North America would register a CAGR of 4.1% by 2026.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/285

The global malaria diagnostics market is highly competitive and the prominent players in the market have adopted various strategies to garner maximum market share which contributes to the market growth. These include collaboration, product launch, partnership, and acquisition. Major players operating in the market include Abbott Laboratories, Access Bio. Inc., Atlas Medical, Biomérieux SA, Bio-Rad Laboratories, Inc., Meridian Bioscience Inc, Novartis AG, Olympus Corporation, Premier Medical Corporation Pvt Ltd. and Siemens AG.

Read More: https://www.alliedmarketresearch.com/malaria-diagnostics-market

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Malaria Diagnostics Market Will Generate New Growth Opportunities in the next upcoming year | Access Bio. Inc., Atlas Medical, Biomérieux SA, Bio-Rad Laboratories, Inc., Meridian Bioscience Inc, Novartis AG here

News-ID: 2308164 • Views:

More Releases from Allied Market Research

Indonesia Food Flavor Market to Grow At a CAGR of 4.8% and Surpass USD 267.5 Million by 2035
Indonesia Food Flavor Market to Grow At a CAGR of 4.8% and Surpass USD 267.5 Mil …
According to the report published by Allied Market Research, The Indonesia food flavor market for the 18-34 years age group male population was valued at $153.1 million in 2023 and is projected to reach $267.5 million by 2035, registering a CAGR of 4.8% from 2024 to 2035. Flavors play a vital role in the Indonesian food & beverages industry to improve the taste of food products. It includes fruity, floral, nutty,
FRP Pipe Market to Grow at a Surprising CAGR of 5.5% by 2033, As Revealed In New Report by AMR
FRP Pipe Market to Grow at a Surprising CAGR of 5.5% by 2033, As Revealed In New …
The global FRP pipe market generated $3.7 billion in 2020, and is projected to reach $6.3 billion by 2030, witnessing a CAGR of 5.5% from 2021 to 2030. The report provides a detailed analysis of changing market dynamics, top segments, value chain, key investment pockets, regional scenario, and competitive landscape. Download Sample PDF (210 Pages PDF with Insights): https://www.alliedmarketresearch.com/request-sample/4303 According to the report published by Allied Market Research, the
Premium Salicylic Acid Market Overview 2026, Business Opportunities, Future Growth, 2030
Premium Salicylic Acid Market Overview 2026, Business Opportunities, Future Grow …
According to the report published by Allied Market Research, the global premium salicylic acid market was estimated at $131.4 million in 2020 and is expected to hit $263.9 million by 2030, registering a CAGR of 7.2% from 2020 to 2030. The report provides an in-depth analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive scenario, and wavering market trends. Download Sample PDF
[CAGR of 5.5%] Concrete Conditioner Market Analysis, Global Trends, Size, Segments and Growth till 2030
[CAGR of 5.5%] Concrete Conditioner Market Analysis, Global Trends, Size, Segmen …
According to the report published by Allied Market Research, the global concrete conditioner market was valued at $476.00 million in 2021, and is projected to reach $783.00 million by 2030, growing at a CAGR of 5.5% from 2022 to 2030. Download Sample PDF Brochure @ https://www.alliedmarketresearch.com/request-sample/22696 The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations,

All 5 Releases


More Releases for Malaria

Industry Dynamics of Cerebral Malaria Therapeutics
Global Cerebral Malaria Therapeutics Market: Overview Cerebral malaria, a severe neuropathological complication, primarily caused by Plasmodium falciparum. The infectious disease has become prevalent in tropical and sub-tropical countries. The cerebral malaria therapeutics market has evolved on the back of increased understanding of pathogenesis of the neurological syndrome. A growing array of biomarkers and tool in recent years have helped underpin the growing revenue potential in the market, giving rise to numerous
Malaria Vaccines – Paving the Way for a Malaria-free World
Recent Study on “Malaria Vaccines Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis and Forecast, 2018-2026” Added to Coherent Market Insights Reports Database. Malaria Vaccines Market report 2018-2026 focuses on the major drivers and restraints for the key players. These research report also provides granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. The Malaria Vaccines market research report is a professional
Malaria Disease Drug Pipeline Analysis
“Malaria Disease Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drug profiles being developed for the treatment of Malaria. Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Chemical Formula, Country of Development and detailed analysis on the development process. Insight for each drug
Rising Prevalence of Cerebral Malaria and Increasing Novel Drug Treatment Drives …
Malaria is a mosquito-borne infectious disease affecting humans and animals caused by parasitic protozoan belonging to the plasmodium family. Malaria is typically transmitted from human to human through the bite of an infected Anopheles (female) mosquito. Symptoms of malaria include fever, headache, fatigue, muscle pain, diarrhea, anemia, and vomiting. Severe malaria can cause yellow skin, seizures, coma, or death. Cerebral malaria is a form of severe malaria. Cerebral malaria has
03-08-2017 | Health & Medicine
TMR
Rising Prevalence of Cerebral Malaria and Increasing Novel Drug Treatment Drives …
Malaria is a mosquito-borne infectious disease affecting humans and animals caused by parasitic protozoan belonging to the plasmodium family. Malaria is typically transmitted from human to human through the bite of an infected Anopheles (female) mosquito. Symptoms of malaria include fever, headache, fatigue, muscle pain, diarrhea, anemia, and vomiting. Severe malaria can cause yellow skin, seizures, coma, or death. Cerebral malaria is a form of severe malaria. Cerebral malaria has
Malaria Diagnostics Market : Future Growth Potential Of The Malaria Diagnostic & …
Malaria is caused by the Plasmodium parasite, which is transmitted by the female Anopheles mosquito. As per the WHO, there were around 203 mn cases of malaria worldwide in 2012, resulting in approximately 627,000 deaths. The diagnosis of malaria involves detection with the help of blood tests and microscopy. Early and accurate diagnosis of malaria is vital for the rapid recovery of the patient and this has raised investments in